@article{42069bbf09704cd6b0efe799b42770d5,
title = "Musashi1 contribution to glioblastoma development via regulation of a network of dna replication, cell cycle and division genes",
abstract = "RNA-binding proteins (RBPs) function as master regulators of gene expression. Alterations in their levels are often observed in tumors with numerous oncogenic RBPs identified in recent years. Musashi1 (Msi1) is an RBP and stem cell gene that controls the balance between selfrenewal and differentiation. High Msi1 levels have been observed in multiple tumors including glioblastoma and are often associated with poor patient outcomes and tumor growth. A comprehensive genomic analysis identified a network of cell cycle/division and DNA replication genes and established these processes as Msi1{\textquoteright}s core regulatory functions in glioblastoma. Msi1 controls this gene network via two mechanisms: direct interaction and indirect regulation mediated by the transcription factors E2F2 and E2F8. Moreover, glioblastoma lines with Msi1 knockout (KO) displayed increased sensitivity to cell cycle and DNA replication inhibitors. Our results suggest that a drug combination strategy (Msi1 + cell cycle/DNA replication inhibitors) could be a viable route to treat glioblastoma.",
keywords = "Cell cycle, Cell division, DNA replication, E2F2, E2F8, Glioblastoma, Musashi1",
author = "Mirella Baroni and Caihong Yi and Saket Choudhary and Xiufen Lei and Adam Kosti and Denise Grieshober and Mitzli Velasco and Mei Qiao and Burns, {Suzanne S.} and Araujo, {Patricia R.} and Talia Delambre and Son, {Mi Young} and Michelina Plateroti and Ferreira, {Marco A.R.} and Paul Hasty and Penalva, {Luiz O.F.}",
note = "Funding Information: Funding: This work was supported by NIH grant 2R01 HG006015 and 1 R21 NS113344-01A1 to LOFP. MB was supported by the Coordena{\c c}{\~a}o de Aperfei{\c c}oamento de Pessoal de N{\'i}vel Superior-Brazil (CAPES)-Finance Code 001. CY was sponsored by the Second Xiangya Hospital of Central South University (CSU). AK was supported by NIH Supplement 2R01 HG006015 and the Greehey Foundation. PRA was supported by Cancer Prevention and Research Institute of Texas (CPRIT)-RP140105. DG was sponsored by the DAAD (Germany). TD was supported by a Voelcker scholarship. Funding Information: Acknowledgments: RNA-seq data were generated at the Genome Sequencing Facility, which is supported by UT Health San Antonio, NIH-NCI P30 CA054174 (Mays Cancer Center, UT Health San Antonio), NIH Shared Instrument grant 1S10OD021805-01, and CPRIT Core Facility Award (RP160732). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = apr,
day = "1",
doi = "10.3390/cancers13071494",
language = "English (US)",
volume = "13",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",
}